Table 3. Fatal and Non-Fatal Events Through 12-Weeks.

Event		Sertraline N=234	Placebo N=235	P-value
All cause mortality, No. (%)		18 (7.7)	15 (6.8)	.58
	Cardiovascular death, No. (%)	16 (6.8)	10 (4.3)	.59
Non-fatal cardiovascular event, No. (%)		47 (20.1)	55 (23)	.39
	Acute myocardial infarction, No. (%)	1 (0.4)	0	.31
	Arrhythmia, No. (%)	4 (1.7)	6 (2.6)	.53
	Cardiac syncope, No., (%)	0	1 (0.4)	.32
	Cerebrovascular accident, No. (%)	2 (0.8)	1 (0.4)	.56
	Exacerbation of heart failure, No. (%)	19 (8.1)	30 (12.8)	.1
	Unstable angina, No. (%)	7 (3)	5 (2.1)	.55
	Other non-fatal cardiovascular event, No. (%)	14 (6)	12 (5.1)	.68
All cause mortality or non-fatal cardiovascular event, No. (%)		65 (29.4)	70 (29.8)	.63
Heart failure hospitalization or death, No. (%)		37 (15.8)	45 (19.2)	.34